Literature DB >> 2209253

Effect of nicotine on dynamic function of brain catecholamine neurons.

T H Svensson1, J Grenhoff, G Engberg.   

Abstract

Burst firing in the mesolimbocortical dopamine (DA) neurons, originating in the ventral tegmental area (VTA), is facilitated by systemic administration of nicotine. Pharmacological results show that bursting in VTA-DA cells is critically dependent on a tonic, excitatory amino acid drive, probably originating from the medial prefrontal cortex. Cold inactivation of the prefrontal cortex caused pacemaker-like firing of VTA-DA cells, an effect partly antagonized by systemic nicotine. Clinically, hypofrontality has been associated with negative symptoms in chronic schizophrenia and with chronic alcoholism. Thus, smoking may provide a means to partially restore the dynamics of the VTA-DA system in such disorders. Intravenous nicotine also induces a selective activation of bursting in noradrenaline neurons of the pontine nucleus locus ceruleus. Pharmacological and physiological experiments clearly suggest that this effect is indirect, e.g. peripherally elicited and relayed to the locus ceruleus through its excitatory amino acid input from the paragigantocellular nucleus. The locus ceruleus activation is rapid in onset, dose dependent, short lasting and can be repeated within minutes. This effect of nicotine, which would imply an instant coping response, may be relevant to nicotine dependence, particularly in depressive states.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209253     DOI: 10.1002/9780470513965.ch10

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  12 in total

Review 1.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

2.  Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms.

Authors:  A R Caggiula; L H Epstein; K A Perkins; S Saylor
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens.

Authors:  M Nisell; M Marcus; G G Nomikos; T H Svensson
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 4.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

Review 5.  [Why do schizophrenic patients smoke?].

Authors:  K Cattapan-Ludewig; S Ludewig; E Jaquenoud Sirot; M Etzensberger; F Hasler
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

Review 6.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

7.  Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.

Authors:  J Grenhoff; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

8.  Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self-administration and after extinction in rats.

Authors:  Fan Wang; Hao Chen; Burt M Sharp
Journal:  J Neurochem       Date:  2008-05-03       Impact factor: 5.372

Review 9.  Molecular mechanisms underlying the motivational effects of nicotine.

Authors:  Darlene H Brunzell; Marina R Picciotto
Journal:  Nebr Symp Motiv       Date:  2009

10.  Haloperidol increases smoking in patients with schizophrenia.

Authors:  J P McEvoy; O Freudenreich; E D Levin; J E Rose
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.